Research map: A transcriptional signature of resting mast cells is associated with improved disease outcome in HR+HER2- breast cancer

Back to the article

Papers in this map

  1. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 · Michael I. Love · 2014 · 104531 citations · Cited by this paper
  2. Invasive lobular carcinoma is characterized by IL33-high differentiated endothelium and IL33 receptor-positive mast-cell enrichment · Jules Cohen · 2026 · Cites this paper
  3. Secreted SULF1 protein modulates CD8 + T cell exhaustion by promoting TAM polarization in gastric cancer · 2026 · Related
  4. limma powers differential expression analyses for RNA-sequencing and microarray studies · Matthew E. Ritchie · 2015 · 44581 citations · Cited by this paper
  5. Immunoglobulin gene polymorphisms shape the naïve B-cell receptor repertoire; relevance to celiac disease · 2026 · Related
  6. Comprehensive Integration of Single-Cell Data · Tim Stuart · 2019 · 17513 citations · Cited by this paper
  7. Structural and functional consequences of IL33 and IL1RL1 coding variants on IL-33/ST2 signaling · 2026 · Related
  8. The Molecular Signatures Database Hallmark Gene Set Collection · Arthur Liberzon · 2015 · 15204 citations · Cited by this paper
  9. Inhibition of cGAS in dendritic cells suppresses maturation and prolongs allograft survival in mice · 2026 · Related
  10. Robust enumeration of cell subsets from tissue expression profiles · Aaron M. Newman · 2015 · 14504 citations · Cited by this paper
  11. RASSF2 promoter hypermethylation determines malignant and microenvironmental features in lung cancer · 2026 · Related
  12. Comprehensive molecular portraits of human breast tumours · The Cancer Genome Atlas Network · 2012 · 12644 citations · Cited by this paper
  13. Radiotherapy combined with anti-PD-1 immunotherapy promotes ferroptosis-driven control of hepatocellular carcinoma · 2025 · Related
  14. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications · Thérese Sørlie · 2001 · 11077 citations · Cited by this paper
  15. The tumoural landscape of lymphocytes and immune pathways in immunotherapy-treated melanoma patients · 2026 · Related
  16. Inferring tumour purity and stromal and immune cell admixture from expression data · Kosuke Yoshihara · 2013 · 10961 citations · Cited by this paper
  17. IRF3 in viral infections: more than just triggering the interferon response · 2025 · Related
  18. SCENIC: single-cell regulatory network inference and clustering · Sara Aibar · 2017 · 7337 citations · Cited by this paper
  19. Regulatory mechanisms of ALKBH5/CIITA axis in the synergistic modulation of hepatocellular carcinoma radiotherapy and immunotherapy · 2026 · Related
  20. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups · METABRIC Group · 2012 · 6509 citations · Cited by this paper
  21. Decoding miRNA-Mediated Immunoregulation in SARS-CoV-2, HBV, HIV, and HSV Infections · 2026 · Related
  22. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics · Jianfang Liu · 2018 · 4062 citations · Cited by this paper
  23. Pembrolizumab for Early Triple-Negative Breast Cancer · Peter Schmid · 2020 · 3305 citations · Cited by this paper
  24. Assessing Bias in Studies of Prognostic Factors · Jill Alison Hayden · 2013 · 3291 citations · Cited by this paper
  25. Breast cancer · Nadia Harbeck · 2019 · 3072 citations · Cited by this paper
  26. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy · Carsten Denkert · 2017 · 2209 citations · Cited by this paper
  27. Genes that mediate breast cancer metastasis to the brain · Paula D. Bos · 2009 · 1916 citations · Cited by this paper
  28. Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer · Andrew N.J. Tutt · 2021 · 1745 citations · Cited by this paper
  29. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data · Francesca Finotello · 2019 · 1727 citations · Cited by this paper
  30. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer · Javier Cortés · 2022 · 1196 citations · Cited by this paper
  31. The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus · Eric Jinsheng Huang · 1990 · 1193 citations · Cited by this paper
  32. Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium · Krisztina M. Zsebo · 1990 · 826 citations · Cited by this paper
  33. Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer · Gabriel N. Hortobagyi · 2022 · 774 citations · Cited by this paper
  34. Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles · Neal G. Copeland · 1990 · 633 citations · Cited by this paper
  35. Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups · Oscar M. Rueda · 2019 · 466 citations · Cited by this paper
  36. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. · Mindy M Tsai · 1991 · 421 citations · Cited by this paper
  37. Immunedeconv: An R Package for Unified Access to Computational Methods for Estimating Immune Cell Fractions from Bulk RNA-Sequencing Data · Gregor Sturm · 2020 · 367 citations · Cited by this paper
  38. Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease · Kyle Tretina · 2019 · 364 citations · Cited by this paper
  39. Candidate ligand for the c‐kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. · K H Nocka · 1990 · 297 citations · Cited by this paper

Source: OpenAlex (CC0)